id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0511-0003,FDA,FDA-2011-N-0511,"Agency Information Collection Activities; Announcement of Office of Management and Budget Approval: Current Good Manufacturing Practices and Related Regulations for Blood and Blood Components, etc.",Notice,Notice of Approval,2012-04-20T04:00:00Z,2012,4,,,2012-04-20T13:19:33Z,2012-09531,0,0,0900006480ff4c83
FDA-2011-N-0511-0002,FDA,FDA-2011-N-0511,"Agency Information Collection Activities; Proposals, Submissions, andApprovals: Current Good Manufacturing Practices and Related Regulations for Blood and Blood Components, etc.",Notice,General Notice,2011-12-22T05:00:00Z,2011,12,,,2011-12-22T14:02:15Z,2011-32778,0,0,0900006480f87c31
FDA-2011-N-0511-0001,FDA,FDA-2011-N-0511,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Current Good Manufacturing Practices and Related Regulations for Blood and Blood Components, etc.",Notice,General Notice,2011-07-28T04:00:00Z,2011,7,2011-07-28T04:00:00Z,2011-09-27T03:59:59Z,2011-07-28T13:18:43Z,2011-19040,0,0,0900006480ece2c9